Star stock-picker Cathie Wood’s ARK Invest just made some big moves—dumping shares of data-mining firm Palantir and gaming platform Roblox while snapping up positions in biotech companies Veracyte and Guardant. It’s a classic ARK shuffle, doubling down on healthcare innovation while stepping back from some of its more speculative tech bets.

Editor’s Note: ARK’s trades always grab attention because Wood’s known for bold, future-focused bets. Selling Palantir and Roblox suggests cooling confidence in those names (or just profit-taking), while the biotech buys signal where she sees the next big growth wave. For investors, it’s a useful pulse check on shifting market trends—especially in volatile sectors like tech and healthcare.